Hit enter to search or ESC to close

~150 Patents Related to Diagnosis and Treatment of Coronavirus

admin

In 2003, Severe Acute Respiratory Syndrome (SARS) led to an epidemic that affected thousands of people globally and killed hundreds. The new respiratory virus that has sickened hundreds of people in China are believed to be a SARS-like coronavirus. In this article, we list patents that are related to diagnosis and treatment of coronavirus to help doctors/researchers quickly develop treatment plans to address the rising concerns over the global outbreak.

Users are encouraged to sign up our patent tracking service to get new patent updates customized to their own interests on a weekly basis. Users are also encouraged to follow us on Twitter and Linkedin for most recent updates.

Patent Digest Team
team@patentdigest.org

TABLE 1: Patents Related to Diagnosis and Treatment of Coronavirus

Title Applicant Assignee Filing Date Grant Date
1 Methods and apparatus to prevent, treat and cure infections of the human respiratory system by pathogens causing severe acute respiratory syndrome (SARS) William Banning Vail, III et al. INHALATION INC. 2003-05-02 2006-05-23
2 Methods for treatment of severe acute respiratory syndrome (SARS) George R. Siber WYETH HOLDINGS CORP. 2003-05-20 2011-02-22
3 Use of hab18g/cd147 molecule as target for antiviral antagonists and thus obtained antiviral antagonist Zhinan Chen 2003-06-09
4 Methods and compositions for detecting sars virus and other infectious agents Ze Li et al. 2003-07-14
5 Method and means for detection of severe acute respiratory syndrome Kuo-Tang Tseng 2003-08-14
6 Compositions and methods for detecting severe acute respiratory syndrome coronavirus Laura Gillim-Ross et al. DIAGNOSTIC HYBRIDS INC. et al. 2003-11-03 2006-10-31
7 Method for preventing and treating severe acute respiratory syndrome Charles Hensley 2004-01-05
8 Diagnostics for sars virus Jimmy Kwang et al. TEMASEK LIFE SCIENCES LABORATORY 2004-02-04
9 Nucleic acid sequences that can be used as primers and probes in the amplification and detection of SARS coronavirus Peter T. G. Sillekens et al. BIOMERIEUX B.V. 2004-03-08 2012-01-31
10 Diagnostic assay for the human virus causing severe acute respiratory syndrome (SARS) Joseph S. M. Peiris et al. THE UNIVERSITY OF HONG KONG 2004-03-24 2007-09-11
11 High-throughput diagnostic assay for the human virus causing severe acute respiratory syndrome (SARS) Joseph S. M. Peiris et al. THE UNIVERSITY OF HONG KONG 2004-03-24 2009-06-16
12 Interferon beta in severe acute respiratory syndrome (sars) Giampiero de Luca ARES TRADING S.A. 2004-04-06
13 Sars Bartholomeus Haagmans et al. 2004-04-08
14 Treatment of SARS in individuals Leif Kongerslev et al. NATLMMUNE A/S et al. 2004-04-08
15 Severe acute respiratory syndrome coronavirus Rino Rappuoli et al. CHIRON CORP. 2004-04-09
16 Rna Interference Mediated Inhibition of Severe Acute Respiratory Syndrome (Sars) Gene Expression Using Short Interfering Nucleic Acid James McSwiggen et al. SIRNA THERAPEUTICS INC. 2004-04-13
17 Compositions and methods for determining the presence of SARS coronavirus in a sample Jeffrey Linnen et al. 2004-04-16
18 Charged polysaccharides resistant to lysosomal degradation during kidney filtration and renal passage and their use to treat or prevent infection by coronaviruses Wayne Comper 2004-04-20
19 Oligonucleotides, reagents and amplification methods for detecting severe acute respiratory syndrome coronavirus Ee Chee Ren et al. GENOME INSTITUTE OF SINGAPORE 2004-04-21 2009-05-05
20 RNAI Agents For Anti-SARS Coronavirus Therapy Quinn Tang et al. INTRADIGM CORP. 2004-04-26
21 Compositions and methods for the treatment of severe acute respiratory syndrome (SARS) Stanley T. Crooke et al. ISIS PHARMACEUTICALS INC. 2004-04-26 2008-03-04
22 SARS virus nucleotide and amino acid sequences and uses thereof Frank Plummer et al. THE PUBLIC HEALTH AGENCY OF CANADA 2004-04-28 2011-03-01
23 Antiviral agents for the treatment, control and prevention of infections by coronaviruses John W. Erickson et al. SEQUOIA PHARMACEUTICALS INC. 2004-04-28 2006-12-19
24 Method and kit for the detection of a novel coronoavirus associated with the severe acute respiratory syndrome (SARS) Thomas Laue QIAGEN DIAGNOSTICS GMBH 2004-04-30 2008-05-20
25 Severe acute respiratory syndrome Barton Haynes et al. 2004-05-10
26 Treating server acute respiratory syndrome William Carter et al. HEMISPHERX BIOPHARMA 2004-05-11
27 Severe acute respiratory syndrome DNA compositions and methods of use Adrian Vilalta et al. VICAL INC. 2004-05-12 2011-12-20
28 Inhibition of gene expression by delivery of specially selected double stranded or other forms of small interfering RNA precursors enabling the formation and function of small interfering RNA in vivo and in vitro Wah Hin Yeung 2004-05-13
29 Interferon for treating or preventing a coronaviral infection Karen Jervis VIRAGEN INC. 2004-05-19
30 Compositions and methods for treatment of severe acute respiratory syndrome (SARS) George R. Siber WYETH 2004-05-20 2010-05-25
31 Isolation and characterization of the precursor virus of human SARS virus: SARS-associated corona virus-like virus Yi Guan et al. THE UNIVERSITY OF HONG KONG 2004-05-24 2008-04-22
32 Use of Ulinastatin and Its Pharmaceutical Composition for Treating Severe Acute Respiratory Syndrome Heliang Fu et al. GUANGDONG TECHPOOL BIOCHEM PHARMA. CO LTD. 2004-05-25
33 Sars Virus Vaccine with Adenovirus Carrier and Preparation Method Thereof, and Use of Sars Virus S Gene for Preparation of Vaccine Wenlin Huang et al. CANCER CENTER SUN YAT-SUN UNIVERSITY 2004-06-04
34 Cell surface expression vector of sars virus antigen and microorganisms transformed thereby Moon-Hee Sung et al. 2004-06-04
35 Glycyrrhizin or derivatives thereof for for treating or preventing severe acute respiratory syndrome (sars) Jindrich Cinatl JOHANN WOLFGANG GOETHE UNIVERSITY 2004-06-07
36 Inhibition of SARS coronavirus infection with clinically approved antiviral drugs Emily Li Chuan Tan et al. GENOME INSTITUTE OF SINGAPORE 2004-06-09 2009-01-27
37 Room decontamination with hydrogen peroxide vapor Thaddeus J. Mielnik et al. STERIS INC. 2004-07-08 2008-04-08
38 Characterization of the earliest stages of the severe acute respiratory syndrome (SARS) virus and uses thereof Guoping Zhao et al. CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI 2004-07-09 2008-01-22
39 Anti-coronavirus drug Nobutaka Fujii et al. ARIGEN PHARMACEUTICALS INC. 2004-07-14 2009-02-24
40 Compositions and methods for diagnosing and treating severe acute respiratory syndrome (SARS) Kwok Tsui et al. THE CHINESE UNIVERSITY OF HONG KONG 2004-07-28
41 Multi-allelic detection of SARS-associated coronavirus Leondios G. Kostrikis BIRCH BIOMEDICAL RESEARCH LLC 2004-08-13 2010-05-04
42 Multi-allelic molecular detection of SARS-associated coronavirus Leondios Kostrikis BIRCH BIOMEDICAL RESEARCH LLC 2004-08-13
43 Inhibitors of SARS 3C like protease Mingying He et al. AGOURON PHARMACEUTICALS INC. 2004-08-13
44 Carboxylic acid derived benzoxazines as agents for the treatment of respiratory diseases Jun Takeuchi et al. ONO PHARMACEUTICAL CO. LTD. 2004-08-31 2010-07-27
45 Epitope profiles of SARS coronavirus Jen-Pin Huang et al. GENESIS BIOTECH INC. 2004-09-08
46 Assay for sars coronavirus by amplification and detection of nucleocapsid rna sequence Jianrong Lou et al. 2004-09-13
47 Prognostic PCR assay for severe acute respiratory syndrome (SARS) Yuk Ming Lo et al. THE CHINESE UNIVERSITY OF HONG KONG 2004-09-23
48 Compositions and methods for diagnosing and preventing severe acute respiratory syndrome (SARS) Tze Ming Leung et al. THE CHINESE UNIVERSITY OF HONG KONG 2004-09-29
49 Angiotensin-converting enzyme-2 as a receptor for the SARS coronavirus Michael Farzan et al. THE BRIGHAM AND WOMEN’S HOSPITAL INC. 2004-10-05
50 Anti-Sars Virus Antibody, Hybridoma Producing the Antibody and Immunoassay Reagent Using the Antibody Yoshiaki Uchida et al. 2004-10-29
51 Baicalin as a treatment for SARS infection Kwok Yung Yuen et al. THE UNIVERSITY OF HONG KONG 2004-11-08 2009-10-20
52 PCR primer set for detecting severe acute respiratory syndrome (SARS)-Coronavirus, method and kit for detecting SARS-Coronavirus using the same Hee-kyun Lim et al. SAMSUNG ELECTRONICS CO. LTD. 2004-11-24 2008-05-20
53 Genetically modified plants comprising SARS-CoV viral nucleotide sequences and methods of use thereof for immunization against SARS Mee Chye et al. THE UNIVERSITY OF HONG KONG 2004-12-03
54 Civet animal model system for Severe Acute Respiratory Syndrome (SARS) coronavirus infection and uses thereof Donglai Wu et al. 2004-12-06
55 Sars coronavirus s proteins and uses thereof Shuo Shen et al. 2004-12-10
56 Sensitive and Specific Test to Detect Sars Coronavirus Masafumi Inoue et al. AGENCY FOR SCIENCE TECHNOLOGY AND RESEARCH 2004-12-17
57 Receptor binding polypeptides Pele Choi Sing Chong et al. NATIONAL HEALTH RESEARCH INSTITUTES 2005-01-10 2009-02-17
58 Compositions And Methods For Modification And Prevention Of Sars Coronavirus Infectivity Brian Tripet et al. THE REGENTS OF THE UNIVERSITY OF COLORADO 2005-02-14
59 Extracts of Scutellaria for the Treatment of Sars Shouming Zhong et al. 2005-02-25
60 Potent and Selective Inhibition by Aurinticarboxylic Acid Runtao He et al. 2005-06-15
61 Vaccine compositions and methods of treating coronavirus infection David Burt et al. ID BIOMEDICAL CORP. OF QUEBEC 2005-06-30
62 SARS CoV main protease inhibitors Su-Ying Wu et al. 2005-07-20
63 Methods for the treatment and prevention of infection using anti-selectin agents Mark A. Jutila et al. 2005-07-27
64 Proteins encoded by the severe acute respiratory syndrome (SARS) coronavirus and a role in apoptosis Wanjin Hong et al. AGENCY FOR SCIENCE TECHNOLOGY AND RESEARCH 2005-08-04
65 SARS vaccine Luis Enjuanes Sanchez et al. CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS 2005-09-02
66 Treating severe and acute viral infections William Carter et al. HEMISPHERX BIOPHARMA 2005-10-06
67 Recombinant virus and use thereof Michinori Kohara et al. POST GENOME INSTITUTE CO. LTD. et al. 2005-10-11
68 Particles for Treatment of Pulmonary Infection David A. Edwards et al. PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2005-10-19
69 Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof Bojian Zheng et al. THE UNIVERSITY OF HONG KONG 2005-10-28
70 Crystal structure of human coronavirus 229E main proteinase and uses for developing SARS inhibitors Rolf Hilgenfeld et al. UNIVERSITAT ZU LUEBECK 2005-11-10
71 3D-structure model of SARS coronavirus 3CL protease and anti-SARS drugs Jianhua Shen et al. SHANGHAI INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF SCIENCES et al. 2005-12-02 2010-02-16
72 Methods for treating severe acute respiratory syndrome Daniel Rossignol 2006-01-13
73 Compositions of coronaviruses with a recombination-resistant genome Ralph S. Baric et al. THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 2006-01-19 2009-11-17
74 Soluble fragments of the SARS-CoV spike glycoprotein Dimiter Dimitrov et al. 2006-01-19
75 Antigenic peptides of SARS coronavirus and uses thereof Jan Ter Meulen et al. 2006-01-20
76 Screening assay for inhibitors of severe acute respiratory syndrome (SARS) using SELDI-TOF Mass Spectrometry Khalid Elased et al. WRIGHT STATE UNIVERSITY 2006-05-12
77 Use of Inhibitors of the Renin-Angiotensin System for the Treatment of Lung Injuries Josef Penninger et al. IMBA-INSTITUTE FUR MOLEKULARE BIOTECHNOLOGIE GMBH 2006-05-19
78 FUSION PROTEINS OF RECOMBINANT SARS CORONAVIRUS STRUCTURAL PROTEINS, THEIR PRODUCTION AND USES Chengyu Jiang et al. CHINESE ACADEMY OF MEDICAL SCIENCES INSTITUTE OF BASIC MEDICAL SCIENCES 2006-06-13
79 Inhibition of SARS-associated coronavirus (SCoV) infection and replication by RNA interference Hsiang-Fu Kung et al. UNIVERSITY OF HONG KONG 2006-06-14
80 Purified trimeric S protein as vaccine against severe acute respiratory syndrome virus infections Yiu Kam et al. 2006-06-27
81 Materials and methods for the detection of severe acute respiratory syndrome virus (SARS) Michael Moser et al. ERAGEN BIOSCIENCES INC. 2006-07-28
82 METHOD FOR MEASUREMENT OF SARS VIRUS NUCLEOCAPSID PROTEIN, REAGENT KIT FOR THE MEASUREMENT, TEST DEVICE, MONOCLONAL ANTIBODY DIRECTED AGAINST SARS VIRUS NUCLEOCAPSID PROTEIN, AND HYBRIDOMA CAPABLE OF PRODUCING THE MONOCLONAL ANTIBODY Kotaro Fujimoto et al. SYSMEX CORP. 2006-10-11
83 Microarray for pathogen identification Michael Lodes et al. COMBIMATRIX CORP. 2006-10-20
84 ANTIVIRAL AGENTS FOR THE TREATMENT, CONTROL AND PREVENTION OF INFECTIONS BY CORONAVIRUSES John Erickson et al. SEQUOIA PHARMACEUTICALS INC. 2006-11-09
85 Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with SARS corona virus spike protein Ralf Altmeyer et al. 2006-12-04
86 BENZOPYRANONE DERIVATIVES AND THEIR USE AS ANTI-VIRAL AGENTS Chum Mok Puah et al. SINGAPORE POLYTECHNIC et al. 2006-12-15
87 Immunoconjugates for treatment of infectious diseases Le Sun 2007-01-19
88 Soluble Fragments of The Sars-Cov Spike Glycoprotein Dimiter S. Dimitrov et al. 2007-01-19
89 Treating severe acute respiratory syndrome William A. Carter et al. HEMISPHERX BIOPHARMA 2007-01-26 2010-03-16
90 Coronavirus isolated from humans Paul A. Rota et al. THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES CENTERS FOR DISEASE CONTROL AND PREVENTION 2007-05-14 2010-08-17
91 Human virus causing severe acute respiratory syndrome (SARS) and uses thereof Joseph Sriyal Malik Peiris et al. VERSITECH LTD. 2007-06-08 2010-08-31
92 Treating severe and acute viral infections William A. Carter et al. HEMISPHERX BIOPHARMA 2007-08-02
93 Methods and apparatus for a remote, noninvasive technique to detect core body temperature in a subject via thermal imaging Gary L. McQuilkin 2008-02-29
94 COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING SEVERE ACUTE RESPIRATORY SYNDROME (SARS) Kwok Wing TSUI et al. THE CHINESE UNIVERSITY OF HONG KONG 2008-04-03
95 PCR PRIMER SET DETECTING SEVERE ACUTE RESPIRATORY SYNDROME (SARS)-CORONAVIRUS, METHOD AND KIT FOR DETECTING SARS-CORONAVIRUS USING THE SAME Hee-kyun LIM et al. SAMSUNG ELECTRONICS CO. LTD. 2008-04-21
96 METHOD FOR DETECTING SARS CORONAVIRUS Harumi MINEKAWA et al. EIKEN KAGAKU KABUSHIKI KAISHA 2008-06-10
97 Recombinant SARS-CoV nsp12 and the use of thereof and the method for producing it Jong Won Oh et al. INDUSTRY-ACADEMIC COOPERATION FOUNDATION YONSEI UNIVERSITY KOOKMIN UNIVERSITY INDUSTRY ACADEMY COOPERATION FOUNDATION 2008-06-13 2013-06-25
98 COMPOSITIONS AND METHODS FOR TREATING CORONAVIRUS INFECTION AND SARS Lawrence M. BLATT THREE RIVERS PHARMACEUTICALS LLC 2008-07-29
99 RNA Interference Mediated Inhibition of Severe Acute Respiratory Syndrome (SARS) Virus Gene Expression Using Short Interfering Nucleic Acid (siNA) James McSwiggen SIRNA THERAPEUTICS INC. 2008-11-17
100 Assay for SARS coronavirus by amplification and detection of the replicase sequence Jianrong Lou et al. BECTON DICKINSON AND CO. 2009-02-03
101 Non-Competitive Internal Controls for Use in Nucleic Acid Tests Jill Detmer et al. SIEMENS HEALTHCARE DIAGNOSTICS INC. 2009-03-19
102 High-Throughput Diagnostic Assay For the Human Virus Causing Severe Acute Respiratory Syndrome (SARS) Joseph S.M. Peiris et al. 2009-06-12
103 COMPOUNDS AND METHODS FOR TREATING RESPIRATORY DISEASES Arun K. Ghosh et al. THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS et al. 2009-08-21
104 Cytotoxic T cell epitope peptide for SARS coronavirus, and use thereof Masanori Matsui et al. NOF CORP. et al. 2009-11-27 2014-09-09
105 ETHYNYLINDOLE COMPOUNDS Kazuyuki OHMOTO et al. ONO PHARMACEUTICAL CO. LTD. 2009-12-22
106 SARS vaccine compositions and methods of making and using them Hassibullah Akeefe et al. ELI LILLY AND CO. 2009-12-28
107 Human virus causing severe acute respiratory syndrome (SARS) and uses thereof Joseph S. M. Peiris et al. VERSITECH LTD. 2010-02-10 2013-01-29
108 Strain of SARS-associated coronavirus and applications thereof Sylvie Van Der Werf et al. INSTITUT PASTEUR et al. 2010-04-06 2013-01-01
109 PEPTIDE COMPOUNDS FOR DETECTING OR INHIBITING SARS CORONAVIRUS AND APPLICATION THEREOF Soo-Hyung LEE et al. ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE 2010-05-26
110 Substituted indole derivatives for the treatment of respiratory diseases Jun Takeuchi et al. ONO PHARMACEUTICAL CO. LTD. 2010-06-01 2012-11-27
111 Chimaeric protein Paul Britton et al. THE PIRBRIGHT INSTITUTE 2010-07-05 2014-09-09
112 METHODS FOR DETERMINING THE PRESENCE OF SARS CORONAVIRUS IN A SAMPLE Daniel L. KACIAN GEN-PROBE INC. 2010-07-06
113 Inhibition of TCR signaling with peptide variants Alexander B. Sigalov SIGNABLOK INC. 2010-09-30 2018-11-27
114 USES OF INTERFERONS WITH ALTERED SPATIAL STRUCTURE Guangwen Wei 2010-10-15
115 Compositions And Methods For Detecting Severe Acute Respiratory Syndrome Coronavirus David R. Scholl et al. DIAGNOSTIC HYBRIDS INC. 2010-12-07
116 Five-membered iminocyclitol derivatives as selective and potent glycosidase inhibitors: new structures for antivirals and osteoarthritis therapeutics Pi-Hui Liang et al. ACADEMIA SINICA TAIWAN 2011-02-24 2012-09-25
117 Surfactant composition Johann Martin Van Zyl et al. STELLENBOSCH UNIVERSITY 2011-02-25 2018-11-13
118 USE OF PROTEINS AND PEPTIDES ENCODED BY THE GENOME OF A NOVEL SARS-ASSOCIATED CORONAVIRUS STRAIN Sylvie VAN DER WERF et al. INSTITUT PASTEUR CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE AND UNIVERSITE PARIS 2011-07-20
119 Canine coronavirus vaccine Nicola Decaro et al. Canio Buonavoglia 2012-06-26 2015-12-01
120 Broad-spectrum antivirals against 3C or 3C-like proteases of picornavirus-like supercluster: picornaviruses, caliciviruses and coronaviruses KANSAS STATE UNIVERSITY RESEARCH FOUNDATION et al. KANSAS STATE UNIVERSITY RESEARCH FOUNDATION et al. 2012-09-27 2016-10-25
121 Methods For Inhibiting Viruses By Targeting Cathepsin-L Cleavage Sites In The Viruses’ Glycoproteins THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS 2013-04-04
122 MACROCYCLIC AND PEPTIDOMIMETIC COMPOUNDS AS BROAD-SPECTRUM ANTIVIRALS AGAINST 3C OR 3C-LIKE PROTEASES OF PICORNAVIRUSES, CALICIVIRUSES AND CORONAVIRUSES KANSA STATE UNIVERSITY RESEARCH FOUNDATION et al. 2013-05-02
123 Immunogenic Composition for MERS Coronavirus Infection Yusen ZHOU et al. 2014-02-28
124 IMMUNOGENIC MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS (MERS-CoV) COMPOSITIONS AND METHODS NOVAVAX INC. 2014-09-19
125 METHODS AND COMPOSITIONS FOR CORONAVIRUS DIAGNOSTICS AND THERAPEUTICS THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 2014-10-14
126 THERAPIES, VACCINES, AND PREDICTIVE METHODS FOR MIDDLE EAST RESPIRATORY SYNDROME VIRUS (MERS CoV) Samuel BOGOCH et al. 2014-10-16
127 HUMAN MONOCLONAL ANTIBODIES AGAINST THE MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS (MERS-COV) AND ENGINEERED BISPECIFIC FUSIONS WITH INHIBITORY PEPTIDES THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERV et al. 2014-10-16
128 A NOVEL SARS IMMUNOGENIC COMPOSITION BAYLOR COLLEGE OF MEDICINE BAYLOR COLLEGE OF MEDICINE 2014-11-21
129 USES OF INTERFERONS WITH ALTERED SPATIAL STRUCTURE SUPERLAB FAR EAST LTD. 2015-01-28
130 METHODS AND COMPOSITIONS FOR CHIMERIC CORONAVIRUS SPIKE PROTEINS THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 2015-03-20
131 Methods of treating and prophylactically protecting mammalian patients infected by viruses classified in Baltimore group V TAMIR BIOTECHNOLOGY INC. TAMIR BIOTECHNOLOGY INC. 2015-06-10 2018-03-20
132 EV576 FOR USE IN THE TREATMENT OF VIRAL INFECTIONS OF THE RESPIRATORY TRACT VOLUTION IMMUNO PHARMACEUTICALS SA VOLUTION IMMUNO PHARMACEUTICALS SA 2016-07-22
133 CORONAVIRUS PROTEINS AND ANTIGENS MJ BIOLOGICS INC. MJ BIOLOGICS INC. 2016-08-04
134 sirna/Nanoparticle Formulations for Treatment of Middle-East Respiratory Syndrome Coronaviral Infection SIRNAOMICS INC. SIRNAOMICS INC. 2016-09-07
135 CORONAVIRUSES EPITOPE-BASED VACCINES RAMOT AT TEL-AVIV UNIVERSITY LTD. RAMOT AT TEL-AVIV UNIVERSITY LTD. 2016-09-15
136 METHODS OF TREATING ZIKA VIRUS, MERS-COV, CHIKUNGUNYA, VENEZUELAN EQUINE ENCEPHALITUS, AND RHINOVIRUS IN MAMMALIAN PATIENTS TAMIR BIOTECHNOLOGY INC. TAMIR BIOTECHNOLOGY INC. 2017-02-09
137 Device to Kill Micro-Organisms Inside the Respiratory Tract Mohamed A Basiony 2017-03-28
138 MULTIVALENT VACCINES FOR RABIES VIRUS AND CORONOVIRUSES THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVIC et al. 2017-03-31
139 IMMUNOGENIC COMPOSITION FOR MERS CORONAVIRUS INFECTION NEW YORK BLOOD CENTER INC. 2017-11-17
140 MERS CORONAVIRUS VACCINE CUREVAC AG 2017-12-22
141 RECOMBINANT SUPER-COMPOUND INTERFERON AND USES THEREOF SUPERLAB FAR EAST LTD. 2018-03-02
142 MERS-CoV Vaccine THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA et al. 2018-06-29
143 INHIBITION OF TCR SIGNALING WITH PEPTIDE VARIANTS SIGNABLOK INC. 2018-10-22
144 USE OF ASC AND ASC-CM TO TREAT ARDS, SARS, AND MERS INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORP. et al. INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORP. et al. 2018-10-31
145 MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS NEUTRALIZING ANTIBODIES AND METHODS OF USE THEREOF DANA-FARBER CANCER INSTITUTE INC. 2018-11-19
146 TREATMENT OF MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS ANSUN BIOPHARMA INC. 2019-03-05
147 MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS IMMUNOGENS, ANTIBODIES, AND THEIR USE THE U.S.A. AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES THE U.S.A. AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES 2019-05-03
148 Human Antibodies to Middle East Respiratory Syndrome – Coronavirus Spike Protein REGENERON PHARMACEUTICALS INC. 2019-08-02
149 Methods and kits for detecting SARS-associated coronavirus Thomas Briese et al. THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2004-01-23 2009-09-01
150 SARS-coronavirus virus-like particles and methods of use Jens Herold 2004-05-04
151 Compositions and methods for detecting a non plus-stranded RNA virus David R. Scholl et al. DIAGNOSTIC HYBRIDS INC. 2004-11-03 2010-12-07
152 Antibodies against SARS-CoV and methods of use thereof Wayne Marasco et al. 2004-11-24
153 Anti-Sars Monoclonal Antibodies Jody Berry et al. 2004-12-06
154 Compositions against SARS-coronavirus and uses thereof Jan Henrik Ter Meulen et al. CRUCELL HOLLAND B.V. 2005-11-10 2012-01-31
155 Binding molecules against SARS-coronavirus and uses thereof Jan H. Ter Meulen et al. CRUCELL HOLLAND B.V. 2009-11-16